`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`NALOX-1 PHARMACEUTICALS, LLC,
`Petitioner,
`
`v.
`
`ADAPT PHARMA OPERATIONS LIMITED, and
`OPIANT PHARMACEUTICALS, INC.,
`Patent Owners.
`__________________
`
`Case IPR2019-00694
`U.S. Patent 9,629,965
`__________________
`
`JOINT NOTICE OF STIPULATION
`REGARDING SCHEDULING
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2019-00694
`U.S. Patent 9,629,965
`
`
`
`
`Petitioner and Patent Owners jointly submit this paper to provide notice that
`
`the parties have stipulated to different dates for DUE DATES 1 and 2 of the
`
`Board’s Scheduling Order (Paper 11), as amended by the parties’ Amended Joint
`
`Notice Regarding Scheduling (Paper 15).
`
`The stipulated DUE DATES are as follows:
`
`
`DUE DATE 1
`
`DUE DATE 2
`
`
`
`Previous Due Date
`December 18, 2019
`
`March 4, 2020
`
`
`Stipulated Due Date
`December 23, 2019
`
`March 9, 2020
`
`The parties have also stipulated that Petitioner’s objections to evidence
`
`submitted with Patent Owners’ response shall be due on January 8, 2020
`
`(previously January 3, 2020) and that any supplemental evidence in response shall
`
`be served on Petitioner no later than January 22, 2020 (previously January 17,
`
`2020).
`
`
`Dated: December 18, 2019
`
`
`
`/Yelee Y. Kim/
`Yelee Y. Kim (Reg. No. 60,088)
`Janine A. Carlan (Reg. No. 42,387)
`Richard Berman (Reg. No. 39,107)
`Bradford Frese (Reg. No. 69,772)
`Christopher Yaen (Reg. No. 66,563)
`ARENT FOX LLP
`1717 K Street NW
`Washington, DC 20006
`Yelee.Kim@arentfox.com
`
`Respectfully submitted,
`
`/Jessamyn S. Berniker/
`
`Jessamyn S. Berniker (Reg. No. 72,328)
`Ana C. Reyes (Admitted Pro Hac Vice)
`David M. Krinsky (Reg. No. 72,339)
`Anthony H. Sheh (Reg. No. 70,576)
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`jberniker@wc.com
`areyes@wc.com
`
`2
`
`
`
`
`Janine.Carlan@arentfox.com
`Richard.Berman@arentfox.com
`Bradford.Frese@arentfox.com
`Christopher.Yaen@arentfox.com
`
`Counsel for Petitioner
`
`
`Case IPR2019-00694
`U.S. Patent 9,629,965
`
`
`dkrinsky@wc.com
`asheh@wc.com
`EmergentNarcan@wc.com
`
`Counsel for Patent Owner
`Adapt Pharma Operations Ltd.
`
`Jessica Tyrus Mackay (Reg. No. 64,742)
`Ann K. Kotze (Reg. No. 76,570)
`GREEN, GRIFFITH & BORG-BREEN, LLP
`676 North Michigan Avenue
`Suite 3900
`Chicago, IL 60611
`jmackay@greengriffith.com
`akotze@greengriffith.com
`
`Counsel for Patent Owner
`Opiant Pharmaceuticals, Inc.
`
`
`3
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Case IPR2019-00694
`U.S. Patent 9,629,965
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned hereby certifies that a true
`
`
`
`
`
`and correct copy of the foregoing was served on December 18, 2019, by delivering
`
`a copy via electronic mail on the following attorneys of record:
`
`Yelee Y. Kim
`Janine A. Carlan
`Richard Berman
`Bradford Frese
`Christopher Yaen
`ARENT FOX LLP
`1717 K Street NW
`Washington, DC 20006
`Yelee.Kim@arentfox.com
`Janine.Carlan@arentfox.com
`Richard.Berman@arentfox.com
`Bradford.Frese@arentfox.com
`Christopher.Yaen@arentfox.com
`
`/Jessamyn S. Berniker/
`Jessamyn S. Berniker
`Reg. No. 72,328
`
`
`
`
`
`
`
`
`
`
`
`
`
`4
`
`